Inventor · disambiguated record
Hoyong Lim
Also filed as: LIM HOYONG
3 granted patents·5 pending applications·5 citations·filing 2020–2024
61Inventor score
Top patents by PatentIndex Score
8 records- 0192US11970547B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2023·Granted Apr 30, 2024·2 cites·21 claims
- 0292US11649294B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2020·Granted May 16, 2023·3 cites·24 claims
- 0385US12410261B2Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising sameGC CELL CORP·Filed 2024·Granted Sep 9, 2025·0 cites·20 claims
- 0462US2025243461A1Method for introducing target gene into immune cellsGC CELL CORP·Filed 2023·Application pending·0 cites
- 0558US2025282845A1Fusion proteins comprising chimeric antigen receptors and il-15GC CELL CORP·Filed 2022·Application pending·0 cites
- 0653US2023242894A1Novel transplantation cells having reduced immunogenicityGC CELL CORP·Filed 2021·Application pending·0 cites
- 0753US2025073264A1Chimeric antigen receptor comprising an anti-her2 antibody or antigen-binding fragment thereof and natural killer cells comprising the sameARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0852US2024180962A1Treatment of cancer with nk cells and a cd20 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hoyong Lim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →